Free Newsletter
SPOTLIGHT: More good news for Alzheimer's patients
Don't plan the party yet, but there's more good news for Alzheimer's patients and statin makers alike. New research that combined cognitive monitoring before death and brain dissection afterward shows that seniors who'd taken statin drugs to lower their cholesterol had developed fewer of the protein deposits in their brains that are the hallmarks of Alzheimer's Disease. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: